Literature DB >> 30065018

G-protein coupled receptor (GPCR) mutations in lymphoid malignancies: linking immune signaling activation and genetic abnormalities.

Jose Angel Martinez-Climent1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30065018      PMCID： PMC6068038          DOI： 10.3324/haematol.2018.196998

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  29 in total

Review 1.  MALT lymphoma: from morphology to molecules.

Authors:  Peter G Isaacson; Ming-Qing Du
Journal:  Nat Rev Cancer       Date:  2004-08       Impact factor: 60.716

Review 2.  Restructuring G-protein- coupled receptor activation.

Authors:  Martin Audet; Michel Bouvier
Journal:  Cell       Date:  2012-09-28       Impact factor: 41.582

3.  Proper desensitization of CXCR4 is required for lymphocyte development and peripheral compartmentalization in mice.

Authors:  Karl Balabanian; Emilie Brotin; Vincent Biajoux; Laurence Bouchet-Delbos; Elodie Lainey; Odile Fenneteau; Dominique Bonnet; Laurence Fiette; Dominique Emilie; Françoise Bachelerie
Journal:  Blood       Date:  2012-03-20       Impact factor: 22.113

Review 4.  Chronic inflammation and extra-nodal marginal-zone lymphomas of MALT-type.

Authors:  Catherine Thieblemont; Francesco Bertoni; Christiane Copie-Bergman; Andrés J M Ferreri; Maurilio Ponzoni
Journal:  Semin Cancer Biol       Date:  2013-12-09       Impact factor: 15.707

Review 5.  The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance.

Authors:  Emanuele Zucca; Francesco Bertoni
Journal:  Blood       Date:  2016-03-17       Impact factor: 22.113

6.  The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas.

Authors:  J Dierlamm; M Baens; I Wlodarska; M Stefanova-Ouzounova; J M Hernandez; D K Hossfeld; C De Wolf-Peeters; A Hagemeijer; H Van den Berghe; P Marynen
Journal:  Blood       Date:  1999-06-01       Impact factor: 22.113

7.  t(X;14)(p11;q32) in MALT lymphoma involving GPR34 reveals a role for GPR34 in tumor cell growth.

Authors:  Stephen M Ansell; Takashi Akasaka; Ellen McPhail; Michelle Manske; Esteban Braggio; Tammy Price-Troska; Steven Ziesmer; Frank Secreto; Rafael Fonseca; Mamta Gupta; Mark Law; Thomas E Witzig; Martin J S Dyer; Ahmet Dogan; James R Cerhan; Anne J Novak
Journal:  Blood       Date:  2012-09-10       Impact factor: 22.113

8.  Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma.

Authors:  Stephan Hailfinger; Georg Lenz; Vu Ngo; Anita Posvitz-Fejfar; Fabien Rebeaud; Montserrat Guzzardi; Eva-Maria Murga Penas; Judith Dierlamm; Wing C Chan; Louis M Staudt; Margot Thome
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-06       Impact factor: 11.205

9.  Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma.

Authors:  Jagan R Muppidi; Roland Schmitz; Jesse A Green; Wenming Xiao; Adrien B Larsen; Sterling E Braun; Jinping An; Ying Xu; Andreas Rosenwald; German Ott; Randy D Gascoyne; Lisa M Rimsza; Elias Campo; Elaine S Jaffe; Jan Delabie; Erlend B Smeland; Rita M Braziel; Raymond R Tubbs; J R Cook; Dennis D Weisenburger; Wing C Chan; Nagarajan Vaidehi; Louis M Staudt; Jason G Cyster
Journal:  Nature       Date:  2014-09-28       Impact factor: 49.962

10.  Gain-of-function CCR4 mutations in adult T cell leukemia/lymphoma.

Authors:  Masao Nakagawa; Roland Schmitz; Wenming Xiao; Carolyn K Goldman; Weihong Xu; Yandan Yang; Xin Yu; Thomas A Waldmann; Louis M Staudt
Journal:  J Exp Med       Date:  2014-12-08       Impact factor: 14.307
View more
  2 in total

1.  Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Hematolymphoid Proliferations and Neoplasia.

Authors:  Judith A Ferry
Journal:  Head Neck Pathol       Date:  2022-03-21

2.  Rare and potentially pathogenic variants in hydroxycarboxylic acid receptor genes identified in breast cancer cases.

Authors:  Cierla McGuire Sams; Kasey Shepp; Jada Pugh; Madison R Bishop; Nancy D Merner
Journal:  BMC Med Genomics       Date:  2021-12-01       Impact factor: 3.063
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.